Literature DB >> 6413743

Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.

S Rockwell.   

Abstract

The effects of mitomycin C alone and in combination with radiation on the cells of EMT6 mouse mammary tumors in BALB/cKaRw mice were examined. At doses near the toxic level, approximately 98% of the tumor cells were killed by a single injection of mitomycin C. Both proliferating and quiescent cells and both hypoxic and aerobic cells were killed by the drug. Cytotoxicity with mitomycin C occurred rapidly and was apparently complete within 30 minutes after injection of the drug . No evidence was found for repair of potentially lethal mitomycin C damage or sublethal mitomycin C damage by the tumor cells. Mitomycin C and radiation in combination produced an additive cytotoxicity; neither agent was found to alter significantly the shape of the dose-response curve for the other agent. The cytotoxicity of mitomycin C and radiation in combination depended on the sequence and timing of the treatments; additive toxicities were obtained when mitomycin C was given just after, just before, or up to 24 hours before irradiation, but the combination was less effective when mitomycin C was given 2-12 hours after irradiation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413743

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  6 in total

1.  Modulation of the antineoplastic efficacy of mitomycin C by dicoumarol in vivo.

Authors:  S Rockwell; S R Keyes; A C Sartorelli
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Characterization of variant and parental-cross-protective immunity to immunogenic variants of a murine fibrosarcoma using the local adoptive transfer assay.

Authors:  W Simcik; T L Sheu; S J LeGrue
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51.

Authors:  D L Gustafson; C A Pritsos
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.

Authors:  T Bando; K Kasahara; K Shibata; Y Numata; U Heki; H Shirasaki; K Iwasa; M Fujimura; T Matsuda
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions.

Authors:  R S Marshall; M C Paterson; A M Rauth
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

6.  Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.

Authors:  B H Xu; V Gupta; S V Singh
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.